American HealthCare Capital is pleased to introduce a rapidly growing clinical trials business for sale in Central Texas. The company has a database of over 20,000 potential participants in over 10 therapeutic areas, with specialties in Internal Medicine, Cardiology, Rheumatology, Dermatology, Pulmonology, Vaccine Studies, Sleep Disorders, Nephrology, Gastroenterology, and Healthy Volunteers.
Their clinical research team includes 7 professionals with over 40 years of combined experience. They are now enrolling studies for people currently diagnosed with COVID-19, those with COVID-19 Exposure, Asthma, Rheumatoid Arthritis, Gout, and a Detection Test for Colon Cancer. Their upcoming studies include Sleep Apnea, Nonalcoholic Steatohepatitis (NASH), Congestive Heart Failure, Major Depression, and Contact Dermatitis.
In 2020, the company generated $1.2 million in revenue and $899,000 in EBITDA, and they have grown rapidly since then. Between Jan-Jun 2021, the company generated $5.7 million in revenue and $5.2 million in EBITDA, putting them on track to gross $11.4 million by the end of the year with over $10 million in EBITDA.
The asking price for this opportunity is $20 million.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.